fluconazole has been researched along with imipenem, anhydrous in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, SH; Bonacorso, HG; Borchhardt, DM; Coelho, HS; da Silva, FM; Flores, KM; Machado, P; Martins, MA; Santurio, JM; Spader, TB; Zanatta, N | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Cuschieri, P; Galizia, AC; Vassallo, J | 1 |
| Chiodo, F; Frank, G; Manfredi, R; Sabbatani, S | 1 |
| Chang, YL; Chen, JS; Hsu, HH; Hsueh, PR; Lee, YC | 1 |
| Lartigue, MF; Nordmann, P; Poirel, L; Poyart, C; Réglier-Poupet, H | 1 |
| Jongman, LR; Lugtenburg, PJ; Rijnders, BJ; Slobbe, L; Waal, Lv | 1 |
| Arias Rodríguez, M; Palomar Fontanet, R; Quintela Obregón, E; Rodrigo Calabia, E; Salas, C | 1 |
| Li, X; Liu, D; Liu, X; Song, L; Xu, Y; Yu, Z; Zhou, T | 1 |
2 review(s) available for fluconazole and imipenem, anhydrous
| Article | Year |
|---|---|
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Capnocytophaga spp. brain abscess in an immunocompetent host: problems in antimicrobial chemotherapy and literature review.
Topics: Adult; Amikacin; Animals; Anti-Bacterial Agents; Bites and Stings; Brain Abscess; Capnocytophaga; Cats; Clindamycin; Diagnosis, Differential; Fluconazole; Gram-Negative Bacterial Infections; Humans; Imipenem; Male | 2004 |
10 other study(ies) available for fluconazole and imipenem, anhydrous
| Article | Year |
|---|---|
Synthesis, antimicrobial activity, and QSAR studies of furan-3-carboxamides.
Topics: Amides; Antifungal Agents; Fungi; Furans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Quantitative Structure-Activity Relationship; Spectrometry, Mass, Electrospray Ionization | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Mixed pulmonary infection with Nocardia, Candida, methicillin-resistant Staphylococcus aureus, and group D Streptococcus species.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clotrimazole; Drug Therapy, Combination; Fluconazole; Fusidic Acid; Humans; Imipenem; Immunocompromised Host; Male; Methicillin Resistance; Nocardia Infections; Pneumonia; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin | 1996 |
An esophageal mass with coexistent Mycobacterium chelonae and Candida albicans infections in an immunocompetent adult.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Fluconazole; Humans; Imipenem; Immunocompetence; Male; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous | 2006 |
Ertapenem resistance of Escherichia coli.
Topics: Anti-Bacterial Agents; Antifungal Agents; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Fluconazole; Gentamicins; Humans; Imipenem; Immunocompromised Host; Middle Aged; Vancomycin | 2007 |
Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Colistin; Drug Therapy, Combination; Female; Fever of Unknown Origin; Fluconazole; Fluoroquinolones; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Withholding Treatment; Young Adult | 2009 |
[Ochrobactrum anthropi and polymicrobial peritonitis in peritoneal dialysis: a resistance predictor].
Topics: Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluconazole; Glomerulonephritis, IGA; Gram-Negative Bacterial Infections; Humans; Imipenem; Middle Aged; Ochrobactrum anthropi; Peritoneal Dialysis; Peritonitis; Pseudomonas Infections | 2010 |
Preliminary physiologically based pharmacokinetic modeling of renally cleared drugs in Chinese pregnant women.
Topics: Adult; Asian People; Aztreonam; Biological Transport; Ceftazidime; Ceftriaxone; Cefuroxime; Female; Fluconazole; Humans; Imipenem; Kidney; Male; Middle Aged; Models, Biological; Pregnancy; White People; Young Adult | 2020 |